nidan, I don't like the drop in ONXX but I am bothered by it. Initial sales of Carfilzomib were far better than excepted, and Nexavar sales jumped 10% in China. Chalk it up to short term thinking and profit taking. I will add that there is nothing wrong with profit taking. I was about to do some myself but the drop from the low $90s was very rapid. I am biding my time until the stock price rebounds before selling any ONXX.